74
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Stereologic evaluation of the vasculature in a MX1 xenotransplanted tumour model after combinations of treatment with ifosfamide, hyperthermia and irradiation

Pages 237-250 | Published online: 09 Jul 2009

References

  • ANAN, K., MORISAKI, T., KATANO, M., IKUBO, A., KITSUKI, H., UCHIYAMA, A., KUROKI, S., TANAKA, M., and TORISU, M., 1996, Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery, 119, 333–339.
  • BLOOM, H. J. G., and RICHARDSON, W. W., 1957, Histological grading and prognosis in breast cancer, A study of 1409 cases of which 359 have been followed for 15 years. British Journal of Cancer, 11, 359–377.
  • BOSARI, S., LEE, A. K. C., DELELLIS, R. A., WILEY, B. D., HEATLEY, G. J., and SILVERMAN, M. L., 1992, Microvessel quantification and prognosis in invasive breast carcinoma. Human Pathology, 23, 755–761.
  • BRIENDGAARD, H., and GUNDERSEN, H. J. G., 1986, The impact of recent stereological advances on quantitative studies on the nervous system. Journal of Neuroscience Methods, 18, 39–78.
  • BRIZEL, D. M., SCULLY, S. P., HARRELSON, J. M., LAYFIELD, L. J., BEAN, J. M., PROSNITZ, L. R., and DEWHIRST, M. W., 1996, Tumour oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 56, 941–943.
  • BROWN, L. F., BERSE, B., JACKMAN, R. W., TOGNAZZ I, K., GUIDI, A. J., DVORAK, H. F., SENGER, D. R., CONNOLLY, J. L., and SCHNITT, S. J., 1995, Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology, 26, 86–91.
  • CAO, Y O'REILLY, M. S., MARSHALL, B., FLYNN, E., JI, R. W., and FOLKMAN, J., 1998, Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. Journal of Clinical Investigations, 101, 1055–1063.
  • CHALKLEY, H. W., 1943, Method for the quantitative morphologic analysis of tissues. Journal of the National Cancer Institute, 4, 47–53.
  • FEYERABEND, T., STEEVES, R., JAGER, B., WIEDEMANN, G. J., SOMMER, K., RICHTER, E., KATSCHINSKI, D. M., and ROBINS, H. I., 1997, Local hyperthermia, hyperfractionated radiation, and cisplatin in preirradiated recurrent lymph node metastases of recurrent head and neck cancer. International Journal of Oncology, 10, 591–595.
  • FEYERABEND, T., STEEVES, R., WIEDEMANN, G. J., WEISS, C., WAGNER, T., RICHTER, E., and ROBINS, H. I., 1996, Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. Oncology, 53, 214–220.
  • GASPARINI, G., To', M., GION, M., VERDERIO, P., DITTADI, R., HANATANI, M., MATSUBARA, I., VINANTE, O., BONOLDI, E., BORACCHI, P., GATTI, C., SUZUKI, H., and TOMINAGA, T., 1997: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. Journal of the National Cancer Institute, 89, 139–147.
  • GUNDERSEN, H. J. G., 1977, Notes on the estimation of the numerical density of arbitrary profiles: the edge effect Journal of Microscopy, 111, 219–223.
  • GUNDERSEN, H. J. G., BAGGER, P., BENDTSEN, T. F., EVANS, S. M., KORBP, L., MARCUSSEN, N., MO LLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SO RENSEN, F. B., VESTERBY, A., and WEST, M. J., 1988, The new stereological tools: Disector, fractio-nator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 96, 857–881.
  • HARRIS, A. L., ZHANG, H., MOGHADDAM, A., Fox, S., SCOTT, P., PATTISON, A., GATTER, K., STRATFORD, I., and BICKNELL, R., 1996, Breast cancer angiogenesis-new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Research and Treatment, 381, 97–108.
  • HAUG, H., 1979, The evaluation of cell-densities and of nerve-cell-size-distribution by stereological procedures in a layered tissue (cortex cerebri). Microscopica Acta, 82, 147–161.
  • HERBENER, G., GOODFLIESH, R., and FASS-HOLMES, B., 1992, A microcomputer program for evaluating sampling error: an application to stereological methods for electron micro-scopy. Biotechnic & Histochemistry, 67, 165–170.
  • HILMAS, D. E., and GILETTE, E. L., 1974: Morphometric analyses of the microvasculature of tumours during growth and after X-irradiation. Cancer, 33, 103–110.
  • HORSMAN, M. R., and OVERGAARD, J., 1997, Can mild hyperthermia improve tumour oxy-genation? International Journal of Hyperthermia, 13, 141–147.
  • JAIN, R. K., 1988, Determinants of tumour blood flow: a review. Cancer Research, 48, 2641–2658.
  • KLAUBER, N., PARANGI, S., FLYNN, E., HAMEL, E., and D'AmATo, R. J., 1997, Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Research, 57, 81–86.
  • KRUGER, M., 1994, Therapiebedingte Frühveränderungen der Zellkeme des MX1 Mammakarzinoms. Medical Thesis, Liibeck.
  • MARXEN, J., SCHMITT, O., HEITS, F., JELKMANN, W., and HELLWIG, T., 1998, Oxygen regu-lated VEGF gene expression in the human breast cancer cell line MX1 in vitro and in vivo. European Journal of Physiology, 435, R128.
  • MENDOZA, A. S., MENTZ EL, M., KRUGER, M., KRAMMER, H. J., WIEDEMANN, G. J., WAGNER, T., WEISS, C., and KCHNEL, W., 1995, The morphology of xenotransplanted human breast carcinoma MX1 growing in nude mice. A light and transmission electron microscopic study. Annals of Anatomy, 177, 3–10.
  • MENTZEL, M., WIEDEMANN, G., and MENDOZA, A. S., 1994, The effect of ifosfamide on tumour oxygenation at different temperature. Oxygen transport to tissue XV; Proceedings of the 20th ISO TT Conference, edited by P. Vaupel, Mainz, Germany (New York: Plenum Press), pp. 342–354.
  • MONSCHKE, F., MULLER W.-U., WINKLER, U., and STREFFER, C., 1991, Cell proliferation and vascularization in human breast carcinomas. International Journal of Cancer, 49, 812–815.
  • NISHIMURA, Y, MURATA, R., and HIRAOKA, M., 1996, Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia. British Journal of Cancer, 73, 270–274.
  • OBERHOLZER, M., 1983, Morphometrie in der klinischen Pathologie (Berlin, Heidelberg, New York: Springer).
  • OIKAWA, T., SUGANUMA, M., ASHINO FUSE, H., and SHIMAMURA, M., 1992, Okadaic acid is a potent angiogenesis inducer. Japanese Journal of Cancer Research, 83, 6–9.
  • OVERGAARD, J., and OVERGAARD, M., 1987, Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. International Journal of Hyperthermia, 6, 483–501.
  • PANTELOURIS, E. M., and HAIR, J., 1970, Thymus dysgenesis in nude (nu nu) mice. Journal of Embryology and Experimental Morphology, 24, 615–623.
  • PROTOPAPA, E., DELIDES, G. S., and lUvk'sz, L., 1993, Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. European Journal of Cancer, 29A, 1391–1393.
  • RELF, M., LEJEUNE, S., SCOTT, P. A., Fox, S., SMITH, K., LEEK, R., MOGHADDAM, A., WHITEHOUSE, R., BICKNELL, R., and HARRIS, A. L., 1997, Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumour growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Research, 57, 963–969.
  • ROSZINSKI, S., WIEDEMANN, G., JIANG, S. Z., BARETTON, G., WAGNER, T., and WEISS, C., 1991, Effects of hyperthermia and/or hyperglycemia on pH and p02 in well oxygenated xenotransplanted human sarcoma. International Journal of Radiation Oncology Biology Physics, 20, 1273–1280.
  • SCHMITT, O., EGGERS, R., KRUGER, M., MENTZEL, M., MENDOZA, A. S., and KCHNEL, W., 1995, Alterations of the nucleolar organiser regions (AgNORs) in the human MX1 xenograft after thermochemotherapy as detected by automatic image analysis. Journal of Anatomy, 187, 234–235.
  • STOBBE, E. V., 1997, Effekte einer einmaligen Thermotherapie auf das menschliche, xenotrans-plantierte Mammacarcinom MX-1. Medical Thesis, Medical University of Liibeck.
  • Sz ABO, K., and MENDOZ A, A. S., 1988, Developmental studies on the rat vomeronasal organ: vascular pattern and neuroepithelial differentiation. I. Light microscopy: Developmental Brain Research, 39, 253–259.
  • To', M., KONDO, S., SUZUKI, H., YAMAMOTO, Y INADA, K., IMAZAWA, T., TANIGUCHI, T., and TOMINAGA, T., 1996b, Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer, 77, 1101–1106.
  • To', M., YAMAMOTO, Y TANIGUCHI, T., SAJI, S., HAYASHI, K., and TOMINAGA, T., 1996a, Regulation of endothelial growth factor expressions in breast cancer. Gan to Kagaku Ryoho [Japanese Journal of Cancer and Chemotherapy], 23, 75–79.
  • TUBIANA, M., and DUTREIX, J., 1990, Introduction to Radiobiology (London: Taylor & Francis). VAN GRONINGEN, J. P., WENINK, A. C. G., and TESTERS, L. H. M., 1991, Myocardial capillaries: Increase in number by splitting of existing vessels. Anatomy and Embryology, 184, 65–70.
  • WEST, M., and GUNDERSEN, H. J. G., 1988, 3rd practical course on morphometry and stereol-ogy in the neuroscience, Technical report of the Stereological Research Laboratory, University Bartholin, Aarhus.
  • WIEDEMANN, G. J., D'OLEIRE, F., ELEFTHERIADIS, S., KNOP, E., FEDDERSEN, S., KLOUCHE, M., GEISLER, J., MENTZEL, M., SCHMUCKER, P., WEISS, C., and WAGNER, T., 1994, Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Research, 54, 5346–5350.
  • WIEDEMANN, G., MELLA, O., Rosz INSKI, S., WEISS, C., and WAGNER, T., 1992c, Local hyper-thermia enhances mitoxantrone cytotoxicity on human derived breast carcinoma and sarcoma xenografts in nude mice. International Journal of Radiation Oncology Biology Physics, 24, 669–673.
  • WIEDEMANN, G. J., ROBINS, H. I., GUTSCHE, S., KATSCHINSKI, D. M., MENTZEL, M., DEEKEN, M., ELEFTHERIADIS, S., CRAHE, R., WEISS, C., STORER, B., and WAGNER, T., 1996a, Ifosfamide, Carboplatin and etoposide (ICE) combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma: A phase II study. European Journal of Cancer, 32A, 888–892.
  • WIEDEMANN, G. J., ROBINS, H. I., KATSCHINSKI, D. M., MENTZEL, M., D'OLEIRE, F., KUTZ, M., and WAGNER, T., 1997, Systematic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Anticancer Research, 17, 2899–2902.
  • WIEDEMANN, G. J., ROBINS, H. I., KATSCHINSKI, D. M., MENTZEL, M., VAN HEEK, R., BUCSKY, P., GILLIS, W., FEYERABEND, T., D'OLEIRE, F., FREUND, C., ELEFTHERIADIS, S., WEISS, C., and WAGNER, T., 1996b, Klinische Studien zur Kombination von Ifosfamid, Carboplatin und Etoposid (ICE) mit 41.8°C Ganzkörperhyperthermie. Medizinische Klinik, 91, 279–283.
  • WIEDEMANN, G., ROSZINSKI, S., BIERSACK, A., MENTZEL, M., WEISS, C., and WAGNER, T., 1992a, Treatment efficacy, intratumoral p02 and pH during thermochemotherapy in xenotransplanted human tumours growing in nude mice. Contributions to Oncology, 42, 556–565.
  • WIEDEMANN, G., ROSZINSKI, S., BIERSACK, A., WEISS, C., and WAGNER, T., 1992b, Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diarnminedichloro-platinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. Journal of Cancer Research and Clinical Oncology, 118, 129–135.
  • WIEDEMANN, G. J., SIEMENS, H. J., MENTZEL, M., BIERSACK, A., WCOSSMANN, W., KNOCKS, D., WEISS, C., and WAGNER, T., 1993, Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Research, 53, 4268–4272.
  • WOLPERT-DEFILIPPES, M. K., 1979, Antitumour activity of cis-dichlorodiammine-platinum(H). Cancer Treatment Reports, 63, 1453–1458.
  • YOSHIJI, H., GOMEZ, D. E., SHIBUYA, M., and THORGEIRSSON, U. P., 1996, Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Research, 56, 2013–2016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.